Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 751 of 1,261
  1. US 9045728

    Liquid viral formulations

    ONCOLYTICS BIOTECH INC. · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  2. US 9044451

    Use of delta tocopherol for the treatment of lysosomal storage disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  3. US 9046529

    Prostatitis-associated antigens and methods of use thereof

    The Regents of the University of California · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  4. US 9044423

    Alcoholic compositions having a lowered risk of acetaldehydemia

    Deuteria Beverages, LLC · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  5. US 9044420

    Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses

    IMMUNE DESIGN CORP. · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  6. US 9044419

    Vaccine compositions compromising βs-crystallin for inducing immune responses against components of drusen

    Northwestern University · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  7. US 9044392

    Nylon-3 co-polymers and synthetic lung surfactant compositions containing same

    Northwestern University · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  8. US 9044398

    Abuse-deterrent pharmaceutical compositions of opiods and other drugs

    Collegium Pharmaceutical, Inc. · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  9. US 9044381

    Method for delivering drugs to the brain

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  10. US 9044442

    Peptidomimetic compounds as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  11. US 9044457

    Anti-DR4 agonist antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  12. US 9044516

    Pharmaceutical compositions of conjugates formed from polymer derivatives having particular atom arrangements

    Nektar Therapeutics · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  13. US 9044611

    Systems and methods for selectively migrating cells using electric fields

    The Regents of the University of California · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  14. US 9045425

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  15. US 9044391

    Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

    The Board of Regents of the University of Texas System · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  16. US 9045541

    CD47 antibodies and methods of use thereof

    Inhibrx, Inc. · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  17. US 9045559

    Method for screening inhibitors of interleukin-32 (IL-32)

    The Regents of the University of Colorado · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  18. US 9045731

    Compositions and methods for improving the functional efficacy of stem cell-derived cardiomyocytes

    The Regents of the University of California · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  19. US 9045496

    N-substituted oxazinopteridines and oxazinopteridinones

    Takeda Pharmaceutical Company Limited · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  20. US 9045476

    Inhibition of quorum sensing-mediated processes in bacteria

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  21. US 9044473

    Delivery of therapeutic compounds to the brain and other tissues

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  22. US 9043996

    Genetically modified major histocompatibility complex animals

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  23. CA 2931112

    IMMUNOGENES CONTRE PLUSIEURS POLLENS ET PROCEDES ET UTILISATIONS POUR MODULER LA REPONSE IMMUNITAIRE

    LA JOLLA INST ALLERGY & IMMUNOLOGY [US] · Granted May 28, 2015 · Expires May 23, 2035

    granted
  24. WO 2015077442

    IMMUNOGÈNES DE POLLEN DE GRAMINÉE AINSI QUE PROCÉDÉS ET UTILISATIONS POUR LA MODULATION DE LA RÉPONSE IMMUNITAIRE

    JOLLA INST ALLERGY IMMUNOLOG [US] · Granted May 28, 2015 · Expires May 23, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.